Beam Therapeutics BEAM
NASDAQ BEAM
$29.64 +0.18 (+0.61%)
As of: Sep 4, 2026 · 3:59 PM EDT

Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026)

Beam Therapeutics (BEAM) posted quarterly Prepaid Assets of $55.3 million for Q1 2026, up 99.92% year-over-year from $27.7 million in Q1 2025, and up 135.54% quarter-over-quarter from $23.5 million in Q4 2025.

Analysis

Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026) Analysis & Trends

Beam Therapeutics (BEAM) has reported Prepaid Assets for 8 consecutive years, with $55.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Prepaid Assets rose 99.92% year-over-year to $55.3 million; the TTM figure through Mar 2026 stood at $55.3 million (up 99.92% YoY), while the FY2025 annual figure was $23.5 million, down 14.34% from the prior year.
  • Prepaid Assets grew to $55.3 million in Q1 2026 per BEAM's latest filing, from $23.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $55.3 million in Q1 2026 and bottomed at $13.8 million in Q2 2022.
  • Historically, Prepaid Assets has averaged $23.6 million across 5 years, with a median of $23.5 million in 2025.
  • Annual changes were most pronounced in 2022 — Prepaid Assets jumped 100.57% — and 2024, when it declined 17.88%.
  • Beam Therapeutics' Prepaid Assets stood at $14.8 million in 2022, then jumped by 43.39% to $21.2 million in 2023, then grew by 29.49% to $27.4 million in 2024, then retreated by 14.34% to $23.5 million in 2025, then surged by 135.54% to $55.3 million in 2026.
  • Business Quant data shows BEAM's Prepaid Assets at $55.3 million in Q1 2026, $23.5 million in Q4 2025, and $23.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Beam Therapeutics 3.10 Bn 3.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.67 Mn
Mar 31, 2026 55.30 Mn
Dec 31, 2025 23.48 Mn
Sep 30, 2025 23.58 Mn
Jun 30, 2025 25.13 Mn
Mar 31, 2025 27.66 Mn
Dec 31, 2024 27.41 Mn
Sep 30, 2024 19.78 Mn
Jun 30, 2024 21.28 Mn
Mar 31, 2024 27.16 Mn
Dec 31, 2023 21.17 Mn
Sep 30, 2023 24.08 Mn
Jun 30, 2023 21.79 Mn
Mar 31, 2023 23.56 Mn
Dec 31, 2022 14.76 Mn
Sep 30, 2022 14.36 Mn
Jun 30, 2022 13.78 Mn
Mar 31, 2022 16.88 Mn
Dec 31, 2021 7.36 Mn
Sep 30, 2021 8.02 Mn